Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy—Part II. Toxicity, Pharmacokinetics and Biodistribution

• Published in: International journal of molecular sciences Vol. 22; no. 11; p. 5702
• Main Authors: Lankoff, Anna, Czerwińska, Malwina, Walczak, Rafał, Karczmarczyk, Urszula, Tomczyk, Kamil, Brzóska, Kamil, Fracasso, Giulio, Garnuszek, Piotr, Mikołajczak, Renata, Kruszewski, Marcin
• Format: Journal Article
• Language: English
• Published: MDPI 27.05.2021

Metastatic castration-resistant prostate cancer (mCRPC) is a progressive and incurable disease with poor prognosis for patients. Despite introduction of novel therapies, the mortality rate remains high. An attractive alternative for extension of the life of mCRPC patients is PSMA-based targeted radi...